Intraductal papillary mucinous neoplasm of the pancreas – epidemiology, risk factors, diagnosis, and management

References

• Longnecker DAG, Hruban R, Kloppel G. Intraductal papillary-mucinous neoplasms of the pancreas. In: Hamilton S, Aaltonen LA, editors. World Health Organization Classification of tumors. Pathology and genetics of tumors of the digestive system. Lyon: IARC Press; 2000. p. 237–241.
   Google Scholar
• Ohashi KMY, Maruyama M. Four cases of mucin producing cancer of the pancreas on specific findings of the papilla of Vater (in Japanese). Prog Dig Endosc. 1982;20:348–351.
   Google Scholar
• Tollefson MK, Libsch KD, Sarr MG, et al. Intraductal papillary mucinous neoplasm: did it exist prior to 1980? Pancreas. 2003;26:e55–e58.
   PubMedGoogle Scholar
• Werner J, Fritz S, Buchler MW. Intraductal papillary mucinous neoplasms of the pancreas–a surgical disease. Nat Rev Gastroenterol Hepatol. 2012;9:253–259.
   PubMed Web of Science ®Google Scholar
• Kloppel G, Solcia E, Longnecker DS, et al. World Health Organization International. Histological typing of tumors of the exocrine pancreas. Berlin: Springer; 1996. p. 1–61.
   Google Scholar
• Reddy RP, Smyrk TC, Zapiach M, et al. Pancreatic mucinous cystic neoplasm defined by ovarian stroma: demographics, clinical features, and prevalence of cancer. Clin Gastroenterol Hepatol. 2004;2:1026–1031.
   PubMed Web of Science ®Google Scholar
• Shyr YM, Su CH, Tsay SH, et al. Mucin-producing neoplasms of the pancreas. Intraductal papillary and mucinous cystic neoplasms. Ann Surg. 1996;223:141–146.
   PubMed Web of Science ®Google Scholar
• McDonald JM, Williard W, Mais D, et al. The incidence of intraductal papillary mucinous tumors of the pancreas(1). Curr Surg. 2000;57:610–614.
   PubMedGoogle Scholar
• Moris M, Bridges MD, Pooley RA, et al. Association between advances in high-resolution cross-section imaging technologies and increase in prevalence of pancreatic cysts from 2005 to 2014. Clin Gastroenterol Hepatol. 2016;14:585–593.e3.
   PubMed Web of Science ®Google Scholar
• Reid-Lombardo KM, St Sauver J, Li Z, et al. Incidence, prevalence, and management of intraductal papillary mucinous neoplasm in Olmsted County, Minnesota, 1984–2005: a population study. Pancreas. 2008;37:139–144.
   PubMed Web of Science ®Google Scholar
• Klibansky DA, Reid-Lombardo KM, Gordon SR, et al. The clinical relevance of the increasing incidence of intraductal papillary mucinous neoplasm. Clin Gastroenterol Hepatol. 2012;10:555–558.
   PubMed Web of Science ®Google Scholar
• McCarty TR, Njei B. Trends in malignant intraductal papillary mucinous neoplasm in US adults from 1990 to 2010: a SEER database analysis. Gastroenterol Rep. 2016;4:113–118.
   Google Scholar
• Fitzgerald TL, Hickner ZJ, Schmitz M, et al. Changing incidence of pancreatic neoplasms: a 16-year review of statewide tumor registry. Pancreas. 2008;37:134–138.
   PubMed Web of Science ®Google Scholar
• Chang YR, Park JK, Jang JY, et al. Incidental pancreatic cystic neoplasms in an asymptomatic healthy population of 21,745 individuals: large-scale, single-center cohort study. Medicine (Baltimore). 2016;95:e5535.
   PubMed Web of Science ®Google Scholar
• Laffan TA, Horton KM, Klein AP, et al. Prevalence of unsuspected pancreatic cysts on MDCT. AJR Am J Roentgenol. 2008;191:802–807.
   PubMed Web of Science ®Google Scholar
• Zanini N, Giordano M, Smerieri E, et al. Estimation of the prevalence of asymptomatic pancreatic cysts in the population of San Marino. Pancreatology. 2015;15:417–422.
   PubMed Web of Science ®Google Scholar
• Lee KS, Sekhar A, Rofsky NM, et al. Prevalence of incidental pancreatic cysts in the adult population on MR imaging. Am J Gastroenterol. 2010;105:2079–2084.
   PubMed Web of Science ®Google Scholar
• de Oliveira PB, Puchnick A, Szejnfeld J, et al. Prevalence of incidental pancreatic cysts on 3 tesla magnetic resonance. PLoS One. 2015;10:e0121317.
   PubMed Web of Science ®Google Scholar
• Sey MS, Teagarden S, Settles D, et al. Prospective cross-sectional study of the prevalence of incidental pancreatic cysts during routine outpatient endoscopic ultrasound. Pancreas. 2015;44:1130–1133.
   PubMed Web of Science ®Google Scholar
• Ferrone CR, Correa-Gallego C, Warshaw AL, et al. Current trends in pancreatic cystic neoplasms. Arch Surg. 2009;144:448–454.
   PubMedGoogle Scholar
• Kimura W, Nagai H, Kuroda A, et al. Analysis of small cystic lesions of the pancreas. Int J Pancreatol. 1995;18:197–206.
   PubMedGoogle Scholar
• Kosmahl M, Pauser U, Peters K, et al. Cystic neoplasms of the pancreas and tumor-like lesions with cystic features: a review of 418 cases and a classification proposal. Virchows Arch. 2004;445:168–178.
   PubMed Web of Science ®Google Scholar
• Yoon WJ, Lee JK, Lee KH, et al. Cystic neoplasms of the exocrine pancreas: an update of a nationwide survey in Korea. Pancreas. 2008;37:254–258.
   PubMed Web of Science ®Google Scholar
• Ingkakul T, Warshaw AL, Fernandez-Del Castillo C. Epidemiology of intraductal papillary mucinous neoplasms of the pancreas: sex differences between 3 geographic regions. Pancreas. 2011;40:779–780.
   PubMed Web of Science ®Google Scholar
• Capurso G, Boccia S, Salvia R, et al. Risk factors for intraductal papillary mucinous neoplasm (IPMN) of the pancreas: a multicentre case-control study. Am J Gastroenterol. 2013;108:1003–1009.
   PubMed Web of Science ®Google Scholar
• Rezaee N, Khalifian S, Cameron JL, et al. Smoking is not associated with severe dysplasia or invasive carcinoma in resected intraductal papillary mucinous neoplasms. J Gastrointest Surg. 2015;19:656–665.
   PubMed Web of Science ®Google Scholar
• Nakagawa T, Masuda A, Toyama H, et al. Smoking status and the incidence of pancreatic cancer concomitant with intraductal papillary mucinous neoplasm. Pancreas. 2017;46:582–588.
   PubMed Web of Science ®Google Scholar
• Carr RA, Roch AM, Shaffer K, et al. Smoking and IPMN malignant progression. Am J Surg. 2016;213:494–497.
   PubMed Web of Science ®Google Scholar
• Gaujoux S, Salenave S, Ronot M, et al. Hepatobiliary and pancreatic neoplasms in patients with McCune-Albright syndrome. J Clin Endocrinol Metab. 2014;99:E97–E101.
   PubMed Web of Science ®Google Scholar
• Tan MC, Basturk O, Brannon AR, et al. GNAS and KRAS mutations define separate progression pathways in intraductal papillary mucinous neoplasm-associated carcinoma. J Am Coll Surg. 2015;220:845–854.e1.
   PubMed Web of Science ®Google Scholar
• Wu J, Matthaei H, Maitra A, et al. Recurrent GNAS mutations define an unexpected pathway for pancreatic cyst development. Sci Transl Med. 2011;3:92ra66.
   PubMed Web of Science ®Google Scholar
• Potjer TP, Schot I, Langer P, et al. Variation in precursor lesions of pancreatic cancer among high-risk groups. Clin Cancer Res. 2013;19:442–449.
   PubMed Web of Science ®Google Scholar
• Canto MI, Hruban RH, Fishman EK, et al. Frequent detection of pancreatic lesions in asymptomatic high-risk individuals. Gastroenterology. 2012;142:796–804. quiz e14-5.
   PubMed Web of Science ®Google Scholar
• Shi C, Klein AP, Goggins M, et al. Increased prevalence of precursor lesions in familial pancreatic cancer patients. Clin Cancer Res. 2009;15:7737–7743.
   PubMed Web of Science ®Google Scholar
• Rebours V, Couvelard A, Peyroux JL, et al. Familial intraductal papillary mucinous neoplasms of the pancreas. Dig Liver Dis. 2012;44:442–446.
   PubMedGoogle Scholar
• Furukawa T, Takahashi T, Kobari M, et al. The mucus-hypersecreting tumor of the pancreas. Development and extension visualized by three-dimensional computerized mapping. Cancer. 1992;70:1505–1513.
   PubMed Web of Science ®Google Scholar
• Adsay NV, Fukushima N, Furukawa T, et al. WHO Classification of Tumors, Intraductal neoplasms of the pancreas. Lyon, France: WHO Press; 2010.
   Google Scholar
• Sohn TA, Yeo CJ, Cameron JL, et al. Intraductal papillary mucinous neoplasms of the pancreas: an updated experience. Ann Surg. 2004;239:788–797. Discussion 97–9.
   PubMed Web of Science ®Google Scholar
• Kim YI, Shin SH, Song KB, et al. Branch duct intraductal papillary mucinous neoplasm of the pancreas: single-center experience with 324 patients who underwent surgical resection. Korean J Hepatobiliary Pancreat Surg. 2015;19:113–120.
   PubMedGoogle Scholar
• Chari ST, Yadav D, Smyrk TC, et al. Study of recurrence after surgical resection of intraductal papillary mucinous neoplasm of the pancreas. Gastroenterology. 2002;123:1500–1507.
   PubMed Web of Science ®Google Scholar
• He J, Cameron JL, Ahuja N, et al. Is it necessary to follow patients after resection of a benign pancreatic intraductal papillary mucinous neoplasm? J Am Coll Surg. 2013;216:657–665. Discussion 65–7.
   PubMed Web of Science ®Google Scholar
• Kang MJ, Jang JY, Lee KB, et al. Long-term prospective cohort study of patients undergoing pancreatectomy for intraductal papillary mucinous neoplasm of the pancreas: implications for postoperative surveillance. Ann Surg. 2014;260:356–363.
   PubMed Web of Science ®Google Scholar
• Rezaee N, Barbon C, Zaki A, et al. Intraductal papillary mucinous neoplasm (IPMN) with high-grade dysplasia is a risk factor for the subsequent development of pancreatic ductal adenocarcinoma. HPB (Oxford). 2016;18:236–246.
   PubMed Web of Science ®Google Scholar
• Furukawa T, Kloppel G, Volkan Adsay N, et al. Classification of types of intraductal papillary-mucinous neoplasm of the pancreas: a consensus study. Virchows Arch. 2005;447:794–799.
   PubMed Web of Science ®Google Scholar
• Distler M, Kersting S, Niedergethmann M, et al. Pathohistological subtype predicts survival in patients with intraductal papillary mucinous neoplasm (IPMN) of the pancreas. Ann Surg. 2013;258:324–330.
   PubMed Web of Science ®Google Scholar
• Furukawa T, Hatori T, Fujita I, et al. Prognostic relevance of morphological types of intraductal papillary mucinous neoplasms of the pancreas. Gut. 2011;60:509–516.
   PubMed Web of Science ®Google Scholar
• Saito M, Imada H, Suzuki T, et al. Distinct patterns of peritumoral histological findings in subtypes of intraductal papillary mucinous neoplasms of the pancreas. Ann Diagn Pathol. 2015;19:347–352.
   PubMed Web of Science ®Google Scholar
• Schaberg KB, DiMaio MA, Longacre TA. Intraductal papillary mucinous neoplasms often contain epithelium from multiple subtypes and/or are unclassifiable. Am J Surg Pathol. 2016;40:44–50.
   PubMed Web of Science ®Google Scholar
• Kwak HA, Liu X, Allende DS, et al. Interobserver variability in intraductal papillary mucinous neoplasm subtypes and application of their mucin immunoprofiles. Mod Pathol. 2016;29:977–984.
   PubMed Web of Science ®Google Scholar
• Adsay NV, Adair CF, Heffess CS, et al. Intraductal oncocytic papillary neoplasms of the pancreas. Am J Surg Pathol. 1996;20:980–994.
   PubMed Web of Science ®Google Scholar
• Basturk O, Tan M, Bhanot U, et al. The oncocytic subtype is genetically distinct from other pancreatic intraductal papillary mucinous neoplasm subtypes. Mod Pathol. 2016;29:1058–1069.
   PubMed Web of Science ®Google Scholar
• Basturk O, Chung SM, Hruban RH, et al. Distinct pathways of pathogenesis of intraductal oncocytic papillary neoplasms and intraductal papillary mucinous neoplasms of the pancreas. Virchows Arch. 2016;469:523–532.
   PubMed Web of Science ®Google Scholar
• Qi X, Zhao X, Su J, et al. Malignant transformation and overall survival of morphological subtypes of intraductal papillary mucinous neoplasms of the pancreas: a network meta-analysis. Eur J Intern Med. 2015;26:652–657.
   PubMed Web of Science ®Google Scholar
• Koh YX, Zheng HL, Chok AY, et al. Systematic review and meta-analysis of the spectrum and outcomes of different histologic subtypes of noninvasive and invasive intraductal papillary mucinous neoplasms. Surgery. 2015;157:496–509.
   PubMed Web of Science ®Google Scholar
• Yoon WJ, Daglilar ES, Mino-Kenudson M, et al. Characterization of epithelial subtypes of intraductal papillary mucinous neoplasm of the pancreas with endoscopic ultrasound and cyst fluid analysis. Endoscopy. 2014;46:1071–1077.
   PubMed Web of Science ®Google Scholar
• Adsay NV, Pierson C, Sarkar F, et al. Colloid (mucinous noncystic) carcinoma of the pancreas. Am J Surg Pathol. 2001;25:26–42.
   PubMed Web of Science ®Google Scholar
• Mino-Kenudson M, Fernandez-del Castillo C, Baba Y, et al. Prognosis of invasive intraductal papillary mucinous neoplasm depends on histological and precursor epithelial subtypes. Gut. 2011;60:1712–1720.
   PubMed Web of Science ®Google Scholar
• Yopp AC, Katabi N, Janakos M, et al. Invasive carcinoma arising in intraductal papillary mucinous neoplasms of the pancreas: a matched control study with conventional pancreatic ductal adenocarcinoma. Ann Surg. 2011;253:968–974.
   PubMed Web of Science ®Google Scholar
• Waters JA, Schnelldorfer T, Aguilar-Saavedra JR, et al. Survival after resection for invasive intraductal papillary mucinous neoplasm and for pancreatic adenocarcinoma: a multi-institutional comparison according to American Joint Committee on Cancer Stage. J Am Coll Surg. 2011;213:275–283.
   PubMed Web of Science ®Google Scholar
• Adsay NV, Merati K, Nassar H, et al. Pathogenesis of colloid (pure mucinous) carcinoma of exocrine organs: coupling of gel-forming mucin (MUC2) production with altered cell polarity and abnormal cell-stroma interaction may be the key factor in the morphogenesis and indolent behavior of colloid carcinoma in the breast and pancreas. Am J Surg Pathol. 2003;27:571–578.
   PubMed Web of Science ®Google Scholar
• McMillan MT, Lewis RS, Drebin JA, et al. The efficacy of adjuvant therapy for pancreatic invasive intraductal papillary mucinous neoplasm (IPMN). Cancer. 2016;122:521–533.
   PubMed Web of Science ®Google Scholar
• Fukushima N, Mukai K, Sakamoto M, et al. Invasive carcinoma derived from intraductal papillary-mucinous carcinoma of the pancreas: clinicopathologic and immunohistochemical study of eight cases. Virchows Arch. 2001;439:6–13.
   PubMed Web of Science ®Google Scholar
• Yamaguchi K, Kanemitsu S, Hatori T, et al. Pancreatic ductal adenocarcinoma derived from IPMN and pancreatic ductal adenocarcinoma concomitant with IPMN. Pancreas. 2011;40:571–580.
   PubMed Web of Science ®Google Scholar
• Poultsides GA, Reddy S, Cameron JL, et al. Histopathologic basis for the favorable survival after resection of intraductal papillary mucinous neoplasm-associated invasive adenocarcinoma of the pancreas. Ann Surg. 2010;251:470–476.
   PubMed Web of Science ®Google Scholar
• Yamao K, Ohashi K, Nakamura T, et al. The prognosis of intraductal papillary mucinous tumors of the pancreas. Hepatogastroenterology. 2000;47:1129–1134.
   PubMed Web of Science ®Google Scholar
• Suzuki Y, Atomi Y, Sugiyama M, et al. Cystic neoplasm of the pancreas: a Japanese multiinstitutional study of intraductal papillary mucinous tumor and mucinous cystic tumor. Pancreas. 2004;28:241–246.
   PubMed Web of Science ®Google Scholar
• Nara S, Shimada K, Kosuge T, et al. Minimally invasive intraductal papillary-mucinous carcinoma of the pancreas: clinicopathologic study of 104 intraductal papillary-mucinous neoplasms. Am J Surg Pathol. 2008;32:243–255.
   PubMed Web of Science ®Google Scholar
• Nakata K, Ohuchida K, Aishima S, et al. Invasive carcinoma derived from intestinal-type intraductal papillary mucinous neoplasm is associated with minimal invasion, colloid carcinoma, and less invasive behavior, leading to a better prognosis. Pancreas. 2011;40:581–587.
   PubMed Web of Science ®Google Scholar
• Adsay V, Mino-Kenudson M, Furukawa T, et al. Pathologic evaluation and reporting of intraductal papillary mucinous neoplasms of the pancreas and other tumoral intraepithelial neoplasms of pancreatobiliary tract: recommendations of Verona consensus meeting. Ann Surg. 2016;263:162–177.
   PubMed Web of Science ®Google Scholar
• Winter JM, Jiang W, Basturk O, et al. Recurrence and survival after resection of small intraductal papillary mucinous neoplasm-associated carcinomas (</=20-mm invasive component): a multi-institutional analysis. Ann Surg. 2016;263:793–801.
   PubMed Web of Science ®Google Scholar
• Traverso LW, Peralta EA, Ryan JA Jr, et al. Intraductal neoplasms of the pancreas. Am J Surg. 1998;175:426–432.
   PubMed Web of Science ®Google Scholar
• Sahora K, Fernandez-del Castillo C, Dong F, et al. Not all mixed-type intraductal papillary mucinous neoplasms behave like main-duct lesions: implications of minimal involvement of the main pancreatic duct. Surgery. 2014;156:611–621.
   PubMed Web of Science ®Google Scholar
• Barron MR, Roch AM, Waters JA, et al. Does preoperative cross-sectional imaging accurately predict main duct involvement in intraductal papillary mucinous neoplasm? J Gastrointest Surg. 2014;18:447–455. Discussion 5455–5456.
   PubMed Web of Science ®Google Scholar
• Kobari M, Egawa S, Shibuya K, et al. Intraductal papillary mucinous tumors of the pancreas comprise 2 clinical subtypes: differences in clinical characteristics and surgical management. Arch Surg. 1999;134:1131–1136.
   PubMedGoogle Scholar
• Tanaka M, Fernandez-del Castillo C, Adsay V, et al. International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. Pancreatology. 2012;12:183–197.
   PubMed Web of Science ®Google Scholar
• Crippa S, Fernandez-Del Castillo C, Salvia R, et al. Mucin-producing neoplasms of the pancreas: an analysis of distinguishing clinical and epidemiologic characteristics. Clin Gastroenterol Hepatol. 2010;8:213–219.
   PubMed Web of Science ®Google Scholar
• Marchegiani G, Mino-Kenudson M, Sahora K, et al. IPMN involving the main pancreatic duct: biology, epidemiology, and long-term outcomes following resection. Ann Surg. 2015;261:976–983.
   PubMed Web of Science ®Google Scholar
• Hwang DW, Jang JY, Lim CS, et al. Determination of malignant and invasive predictors in branch duct type intraductal papillary mucinous neoplasms of the pancreas: a suggested scoring formula. J Korean Med Sci. 2011;26:740–746.
   PubMed Web of Science ®Google Scholar
• Jang JY, Park T, Lee S, et al. Proposed nomogram predicting the individual risk of malignancy in the patients with branch duct type intraductal papillary mucinous neoplasms of the pancreas. Ann Surg. 2016. [Epub ahead of print].
   PubMed Web of Science ®Google Scholar
• Ceppa EP, Roch AM, Cioffi JL, et al. Invasive, mixed-type intraductal papillary mucinous neoplasm: superior prognosis compared to invasive main-duct intraductal papillary mucinous neoplasm. Surgery. 2015;158:937–944. Discussion 44–45.
   PubMed Web of Science ®Google Scholar
• Okabayashi T, Shima Y, Kosaki T, et al. Invasive carcinoma derived from branch duct-type IPMN may be a more aggressive neoplasm than that derived from main duct-type IPMN. Oncol Lett. 2013;5:1819–1825.
   PubMed Web of Science ®Google Scholar
• Fritz S, Klauss M, Bergmann F, et al. Pancreatic main-duct involvement in branch-duct IPMNs: an underestimated risk. Ann Surg. 2014;260:848–855. Discussion 55–56.
   PubMed Web of Science ®Google Scholar
• Schmidt CM, White PB, Waters JA, et al. Intraductal papillary mucinous neoplasms: predictors of malignant and invasive pathology. Ann Surg. 2007;246:644–651. Discussion 51–54.
   Google Scholar
• Rodriguez JR, Salvia R, Crippa S, et al. Branch-duct intraductal papillary mucinous neoplasms: observations in 145 patients who underwent resection. Gastroenterology. 2007;133:72–79. quiz 309-310.
   PubMed Web of Science ®Google Scholar
• Mori Y, Ohtsuka T, Kono H, et al. Management strategy for multifocal branch duct intraductal papillary mucinous neoplasms of the pancreas. Pancreas. 2012;41:1008–1012.
   PubMed Web of Science ®Google Scholar
• Salvia R, Partelli S, Crippa S, et al. Intraductal papillary mucinous neoplasms of the pancreas with multifocal involvement of branch ducts. Am J Surg. 2009;198:709–714.
   PubMed Web of Science ®Google Scholar
• Castelli F, Bosetti D, Negrelli R, et al. Multifocal branch-duct intraductal papillary mucinous neoplasms (IPMNs) of the pancreas: magnetic resonance (MR) imaging pattern and evolution over time. Radiol Med. 2013;118:917–929.
   PubMed Web of Science ®Google Scholar
• Fritz S, Schirren M, Klauss M, et al. Clinicopathologic characteristics of patients with resected multifocal intraductal papillary mucinous neoplasm of the pancreas. Surgery. 2012;152:S74–S80.
   PubMed Web of Science ®Google Scholar
• Eguchi H, Ishikawa O, Ohigashi H, et al. Role of intraoperative cytology combined with histology in detecting continuous and skip type intraductal cancer existence for intraductal papillary mucinous carcinoma of the pancreas. Cancer. 2006;107:2567–2575.
   PubMed Web of Science ®Google Scholar
• Tamura K, Ohtsuka T, Matsunaga T, et al. Assessment of clonality of multisegmental main duct intraductal papillary mucinous neoplasms of the pancreas based on GNAS mutation analysis. Surgery. 2015;157:277–284.
   PubMed Web of Science ®Google Scholar
• Izawa T, Obara T, Tanno S, et al. Clonality and field cancerization in intraductal papillary-mucinous tumors of the pancreas. Cancer. 2001;92:1807–1817.
   PubMed Web of Science ®Google Scholar
• Matthaei H, Norris AL, Tsiatis AC, et al. Clinicopathological characteristics and molecular analyses of multifocal intraductal papillary mucinous neoplasms of the pancreas. Ann Surg. 2012;255:326–333.
   PubMed Web of Science ®Google Scholar
• Chai H, Brown RE. Field effect in cancer – an update. Ann Clin Lab Sci. 2009;39:331–337.
   PubMed Web of Science ®Google Scholar
• Braakhuis BJ, Tabor MP, Kummer JA, et al. A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications. Cancer Res. 2003;63:1727–1730.
   PubMed Web of Science ®Google Scholar
• Lafemina J, Katabi N, Klimstra D, et al. Malignant progression in IPMN: a cohort analysis of patients initially selected for resection or observation. Ann Surg Oncol. 2013;20:440–447.
   PubMed Web of Science ®Google Scholar
• Winner M, Epelboym I, Remotti H, et al. Predictors of recurrence in intraductal papillary mucinous neoplasm: experience with 183 pancreatic resections. J Gastrointest Surg. 2013;17:1618–1626.
   PubMed Web of Science ®Google Scholar
• Marchegiani G, Mino-Kenudson M, Ferrone CR, et al. Patterns of recurrence after resection of IPMN: who, when, and how? Ann Surg. 2015;262:1108–1114.
   PubMed Web of Science ®Google Scholar
• Bassi C, Sarr MG, Lillemoe KD, et al. Natural history of intraductal papillary mucinous neoplasms (IPMN): current evidence and implications for management. J Gastrointest Surg. 2008;12:645–650.
   PubMed Web of Science ®Google Scholar
• Kanno A, Satoh K, Hirota M, et al. Prediction of invasive carcinoma in branch type intraductal papillary mucinous neoplasms of the pancreas. J Gastroenterol. 2010;45:952–959.
   PubMed Web of Science ®Google Scholar
• Sahora K, Crippa S, Zamboni G, et al. Intraductal papillary mucinous neoplasms of the pancreas with concurrent pancreatic and periampullary neoplasms. Eur J Surg Oncol. 2016;42:197–204.
   PubMed Web of Science ®Google Scholar
• Ideno N, Ohtsuka T, Kono H, et al. Intraductal papillary mucinous neoplasms of the pancreas with distinct pancreatic ductal adenocarcinomas are frequently of gastric subtype. Ann Surg. 2013;258:141–151.
   PubMed Web of Science ®Google Scholar
• Miyasaka Y, Ohtsuka T, Tamura K, et al. Predictive factors for the metachronous development of high-risk lesions in the remnant pancreas after partial pancreatectomy for intraductal papillary mucinous neoplasm. Ann Surg. 2016;263:1180–1187.
   PubMed Web of Science ®Google Scholar
• Kawada N, Uehara H, Nagata S, et al. Imaging morphological changes of intraductal papillary mucinous neoplasm of the pancreas was associated with its malignant transformation but not with development of pancreatic ductal adenocarcinoma. Pancreatology. 2015;15:654–660.
   PubMed Web of Science ®Google Scholar
• Tamura K, Ohtsuka T, Date K, et al. Distinction of invasive carcinoma derived from intraductal papillary mucinous neoplasms from concomitant ductal adenocarcinoma of the pancreas using molecular biomarkers. Pancreas. 2016;45:826–835.
   PubMed Web of Science ®Google Scholar
• Marchegiani G, Malleo G, D'Haese JG, et al. Association between pancreatic intraductal papillary mucinous neoplasms and extrapancreatic malignancies. Clin Gastroenterol Hepatol. 2015;13:1162–1169.
   PubMed Web of Science ®Google Scholar
• Malleo G, Marchegiani G, Borin A, et al. Observational study of the incidence of pancreatic and extrapancreatic malignancies during surveillance of patients with branch-duct intraductal papillary mucinous neoplasm. Ann Surg. 2015;261:984–990.
   PubMed Web of Science ®Google Scholar
• Kawakubo K, Tada M, Isayama H, et al. Incidence of extrapancreatic malignancies in patients with intraductal papillary mucinous neoplasms of the pancreas. Gut. 2011;60:1249–1253.
   PubMed Web of Science ®Google Scholar
• Lennon AM, Manos LL, Hruban RH, et al. Role of a multidisciplinary clinic in the management of patients with pancreatic cysts: a single-center cohort study. Ann Surg Oncol. 2014;21:3668–3674.
   PubMed Web of Science ®Google Scholar
• Italian Association of Hospital G, Endoscopists, Italian Association for the Study of the P, Buscarini E, Pezzilli R, Cannizzaro R, et al. Italian consensus guidelines for the diagnostic work-up and follow-up of cystic pancreatic neoplasms. Dig Liver Dis. 2014;46:479–493.
   PubMedGoogle Scholar
• Kloppel G. Clinicopathologic view of intraductal papillary-mucinous tumor of the pancreas. Hepatogastroenterology. 1998;45:1981–1985.
   PubMed Web of Science ®Google Scholar
• Kim M, Mi Jang K, Kim SH, et al. Diagnostic accuracy of diffusion restriction in intraductal papillary mucinous neoplasm of the pancreas in comparison with "high-risk stigmata" of the 2012 international consensus guidelines for prediction of the malignancy and invasiveness. Acta Radiol. 2017;284185116685921.
   PubMed Web of Science ®Google Scholar
• Birnbaum DJ, Gaujoux S, Berbis J, et al. Surgery for pancreatic neoplasms: how accurate are our surgical indications? Surgery 2017. DOI: 10.1016/j.surg.2017.01.015. [Epub ahead of print].
   PubMed Web of Science ®Google Scholar
• de Pretis N, Mukewar S, Aryal-Khanal A, et al. Pancreatic cysts: diagnostic accuracy and risk of inappropriate resections. Pancreatology. 2017;17:267–272.
   PubMed Web of Science ®Google Scholar
• Salvia R, Malleo G, Marchegiani G, et al. Pancreatic resections for cystic neoplasms: from the surgeon's presumption to the pathologist's reality. Surgery. 2012;152:S135–S142.
   PubMed Web of Science ®Google Scholar
• Tanaka M, Chari S, Adsay V, et al. International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology. 2006;6:17–32.
   PubMed Web of Science ®Google Scholar
• Vege SS, Ziring B, Jain R, Clinical Guidelines C, American Gastroenterology A, et al. American gastroenterological association institute guideline on the diagnosis and management of asymptomatic neoplastic pancreatic cysts. Gastroenterology. 2015;148:819–822. quiz 12–3.
   PubMed Web of Science ®Google Scholar
• Del Chiaro M, Verbeke C, Salvia R, et al. European experts consensus statement on cystic tumours of the pancreas. Dig Liver Dis. 2013;45:703–711.
   PubMedGoogle Scholar
• Falconi M, Crippa S, Chari S, et al. Quality assessment of the guidelines on cystic neoplasms of the pancreas. Pancreatology. 2015;15:463–469.
   PubMed Web of Science ®Google Scholar
• Cahalane AM, Purcell YM, Lavelle LP, et al. Which is the best current guideline for the diagnosis and management of cystic pancreatic neoplasms? An appraisal using evidence-based practice methods. Eur Radiol. 2016;26:3121–3128.
   PubMed Web of Science ®Google Scholar
• Lekkerkerker SJ, Besselink MG, Busch OR, et al. Comparing 3 guidelines on the management of surgically removed pancreatic cysts with regard to pathological outcome. Gastrointest Endosc 2016;85:1025–1031.
   PubMed Web of Science ®Google Scholar
• Jang JY, Park T, Lee S, et al. Validation of international consensus guidelines for the resection of branch duct-type intraductal papillary mucinous neoplasms. Br J Surg. 2014;101:686–692.
   PubMed Web of Science ®Google Scholar
• Yamada S, Fujii T, Murotani K, et al. Comparison of the international consensus guidelines for predicting malignancy in intraductal papillary mucinous neoplasms. Surgery. 2016;159:878–884.
   PubMed Web of Science ®Google Scholar
• Han DH, Lee H, Park JY, et al. Validation of international consensus guideline 2012 for intraductal papillary mucinous neoplasm of pancreas. Ann Surg Treat Res. 2016;90:124–130.
   PubMed Web of Science ®Google Scholar
• Seo N, Byun JH, Kim JH, et al. Validation of the 2012 International consensus guidelines using computed tomography and magnetic resonance imaging: branch duct and main duct intraductal papillary mucinous neoplasms of the pancreas. Ann Surg. 2016;263:557–564.
   PubMed Web of Science ®Google Scholar
• Roch AM, Barron MR, Tann M, et al. Does PET with CT have clinical utility in the management of patients with intraductal papillary mucinous neoplasm? J Am Coll Surg. 2015;221:48–56.
   PubMed Web of Science ®Google Scholar
• Sultana A, Jackson R, Tim G, et al. What is the best way to identify malignant transformation within pancreatic IPMN: a systematic review and meta-analyses. Clin Trans Gastroenterol. 2015;6:e130.
   PubMed Web of Science ®Google Scholar
• Robles EP, Maire F, Cros J, et al. Accuracy of 2012 International Consensus Guidelines for the prediction of malignancy of branch-duct intraductal papillary mucinous neoplasms of the pancreas. United Eur Gastroenterol J. 2016;4:580–586.
   PubMed Web of Science ®Google Scholar
• Ricci C, Casadei R, Taffurelli G, et al. Risk factors for malignancy of branch-duct intraductal papillary mucinous neoplasms: a critical evaluation of the Fukuoka guidelines with a systematic review and meta-analysis. Pancreas. 2016;45:1243–1254.
   PubMed Web of Science ®Google Scholar
• Heckler M, Michalski CW, Schaefle S, et al. The Sendai and Fukuoka consensus criteria for the management of branch duct IPMN – a meta-analysis on their accuracy. Pancreatology. 2017;17:255--262.
   PubMed Web of Science ®Google Scholar
• Wilson GC, Maithel SK, Bentrem D, et al. Are the current guidelines for the surgical management of intraductal papillary mucinous neoplasms of the pancreas adequate? A multi-institutional study. J Am Coll Surg. 2017;224:461--469.
   PubMed Web of Science ®Google Scholar
• Sugimoto M, Elliott IA, Nguyen AH, et al. Assessment of a revised management strategy for patients with intraductal papillary mucinous neoplasms involving the main pancreatic duct. JAMA Surg. 2017;152:e163349.
   PubMed Web of Science ®Google Scholar
• Hackert T, Fritz S, Klauss M, et al. Main-duct intraductal papillary mucinous neoplasm: high cancer risk in duct diameter of 5 to 9 mm. Ann Surg. 2015;262:875–880. Discussion 80–81.
   PubMed Web of Science ®Google Scholar
• Kang MJ, Jang JY, Lee S, et al. Clinicopathological meaning of size of main-duct dilatation in intraductal papillary mucinous neoplasm of pancreas: proposal of a simplified morphological classification based on the investigation on the size of main pancreatic duct. World J Surg. 2015;39:2006–2013.
   PubMed Web of Science ®Google Scholar
• Singhi AD, Zeh HJ, Brand RE, et al. American Gastroenterological Association guidelines are inaccurate in detecting pancreatic cysts with advanced neoplasia: a clinicopathologic study of 225 patients with supporting molecular data. Gastrointest Endosc. 2016;83:1107–1117.e2.
   PubMed Web of Science ®Google Scholar
• Nagata N, Kawazoe A, Mishima S, et al. Development of pancreatic cancer, disease-specific mortality, and all-cause mortality in patients with nonresected IPMNs: a long-term cohort study. Radiology. 2016;278:125–134.
   PubMed Web of Science ®Google Scholar
• Moris M, Raimondo M, Woodward TA, et al. International intraductal papillary mucinous neoplasms registry: long-term results based on the new guidelines. Pancreas. 2017;46:306–310.
   PubMed Web of Science ®Google Scholar
• Crippa S, Bassi C, Salvia R, et al. Low progression of intraductal papillary mucinous neoplasms with worrisome features and high-risk stigmata undergoing non-operative management: a mid-term follow-up analysis. Gut. 2017;66:495–506.
   PubMed Web of Science ®Google Scholar
• Mukewar S, de Pretis N, Aryal-Khanal A, et al. Fukuoka criteria accurately predict risk for adverse outcomes during follow-up of pancreatic cysts presumed to be intraductal papillary mucinous neoplasms. Gut. 2016. [Epub ahead of print]. DOI: 10.1136/gutjnl-2016-311615
   PubMed Web of Science ®Google Scholar
• Kwong WT, Lawson RD, Hunt G, et al. Rapid growth rates of suspected pancreatic cyst branch duct intraductal papillary mucinous neoplasms predict malignancy. Dig Dis Sci. 2015;60:2800–2806.
   PubMed Web of Science ®Google Scholar
• Del Chiaro M, Ateeb Z, Hansson MR, et al. Survival analysis and risk for progression of intraductal papillary mucinous neoplasia of the pancreas (IPMN) under surveillance: a single-institution experience. Ann Surg Oncol. 2017;24:1120–1126.
   PubMed Web of Science ®Google Scholar
• Crippa S, Capurso G, Camma C, et al. Risk of pancreatic malignancy and mortality in branch-duct IPMNs undergoing surveillance: a systematic review and meta-analysis. Dig Liver Dis. 2016;48:473–479.
   PubMedGoogle Scholar
• Couvelard A, Sauvanet A, Kianmanesh R, et al. Frozen sectioning of the pancreatic cut surface during resection of intraductal papillary mucinous neoplasms of the pancreas is useful and reliable: a prospective evaluation. Ann Surg. 2005;242:774–778. Discussion 8–80.
   PubMed Web of Science ®Google Scholar
• Basturk O, Coban I, Adsay NV. Pancreatic cysts: pathologic classification, differential diagnosis, and clinical implications. Arch Pathol Lab Med. 2009;133:423–438.
   PubMed Web of Science ®Google Scholar
• Navez J, Hubert C, Gigot JF, et al. Impact of intraoperative pancreatoscopy with intraductal biopsies on surgical management of intraductal papillary mucinous neoplasm of the pancreas. J Am Coll Surg. 2015;221:982–987.
   PubMed Web of Science ®Google Scholar
• Mori Y, Ohtsuka T, Tamura K, et al. Intraoperative irrigation cytology of the remnant pancreas to detect remnant distinct pancreatic ductal adenocarcinoma in patients with intraductal papillary mucinous neoplasm undergoing partial pancreatectomy. Surgery. 2014;155:67–73.
   PubMed Web of Science ®Google Scholar
• Pea A, Yu J, Rezaee N, et al. Targeted DNA sequencing reveals patterns of local progression in the pancreatic remnant following resection of intraductal papillary mucinous neoplasm (IPMN) of the pancreas. Ann Surg. 2016. [Epub ahead of print].
   PubMed Web of Science ®Google Scholar
• Bhardwaj N, Dennison AR, Maddern GJ, et al. Management implications of resection margin histology in patients undergoing resection for IPMN: a meta-analysis. Pancreatology. 2016;16:309–317.
   PubMed Web of Science ®Google Scholar
• Leng KM, Wang ZD, Zhao JB, et al. Impact of pancreatic margin status and lymph node metastases on recurrence after resection for invasive and noninvasive intraductal papillary mucinous neoplasms of the pancreas: a meta-analysis. Dig Surg. 2012;29:213–225.
   PubMed Web of Science ®Google Scholar
• Frankel TL, LaFemina J, Bamboat ZM, et al. Dysplasia at the surgical margin is associated with recurrence after resection of non-invasive intraductal papillary mucinous neoplasms. HPB (Oxford). 2013;15:814–821.
   PubMed Web of Science ®Google Scholar
• Moriya T, Traverso W. Fate of the pancreatic remnant after resection for an intraductal papillary mucinous neoplasm: a longitudinal level II cohort study. Arch Surg. 2012;147:528–534.
   PubMedGoogle Scholar
• Tamura K, Ohtsuka T, Ideno N, et al. Treatment strategy for main duct intraductal papillary mucinous neoplasms of the pancreas based on the assessment of recurrence in the remnant pancreas after resection: a retrospective review. Ann Surg. 2014;259:360–368.
   PubMed Web of Science ®Google Scholar
• Ohtsuka T, Kono H, Tanabe R, et al. Follow-up study after resection of intraductal papillary mucinous neoplasm of the pancreas; special references to the multifocal lesions and development of ductal carcinoma in the remnant pancreas. Am J Surg. 2012;204:44–48.
   PubMed Web of Science ®Google Scholar
• Schnelldorfer T, Sarr MG, Nagorney DM, et al. Experience with 208 resections for intraductal papillary mucinous neoplasm of the pancreas. Arch Surg. 2008;143:639–646. Discussion 46.
   PubMedGoogle Scholar
• Simons JP, Shah SA, Ng SC, et al. National complication rates after pancreatectomy: beyond mere mortality. J Gastrointest Surg. 2009;13:1798–1805.
   PubMed Web of Science ®Google Scholar
• Bhayani NH, Miller JL, Ortenzi G, et al. Perioperative outcomes of pancreaticoduodenectomy compared to total pancreatectomy for neoplasia. J Gastrointest Surg. 2014;18:549–554.
   PubMed Web of Science ®Google Scholar
• Reddy S, Wolfgang CL, Cameron JL, et al. Total pancreatectomy for pancreatic adenocarcinoma: evaluation of morbidity and long-term survival. Ann Surg. 2009;250:282–287.
   PubMed Web of Science ®Google Scholar
• Crippa S, Tamburrino D, Partelli S, et al. Total pancreatectomy: indications, different timing, and perioperative and long-term outcomes. Surgery. 2011;149:79–86.
   PubMed Web of Science ®Google Scholar
• Ito T, Doi R, Yoshizawa A, et al. The distribution of atypical epithelium in main-duct type intraductal papillary mucinous neoplasms of the pancreas. J Hepatobiliary Pancreat Sci. 2011;18:241–246. Discussion 6–9.
   PubMed Web of Science ®Google Scholar
• Jang JY, Kim SW, Ahn YJ, et al. Multicenter analysis of clinicopathologic features of intraductal papillary mucinous tumor of the pancreas: is it possible to predict the malignancy before surgery? Ann Surg Oncol. 2005;12:124–132.
   PubMed Web of Science ®Google Scholar
• Wang X, Hong X, Pang H, et al. Selecting optimal surgical procedures for intraductal papillary mucinous neoplasm (IPMN): an analysis based on the Surveillance, Epidemiology, and End Result registry database. Eur J Surg Oncol. 2016;42:1526–1532.
   PubMed Web of Science ®Google Scholar
• Cuillerier E, Cellier C, Palazzo L, et al. Outcome after surgical resection of intraductal papillary and mucinous tumors of the pancreas. Am J Gastroenterol. 2000;95:441–445.
   PubMed Web of Science ®Google Scholar
• Sauvanet A, Gaujoux S, Blanc B, et al. Parenchyma-sparing pancreatectomy for presumed noninvasive intraductal papillary mucinous neoplasms of the pancreas. Ann Surg. 2014;260:364–371.
   PubMed Web of Science ®Google Scholar
• Nakao A, Fernandez-Cruz L. Pancreatic head resection with segmental duodenectomy: safety and long-term results. Ann Surg. 2007;246:923–928. Discussion 9–31.
   PubMed Web of Science ®Google Scholar
• Kaiser J, Fritz S, Klauss M, et al. Enucleation: a treatment alternative for branch duct intraductal papillary mucinous neoplasms. Surgery. 2017;161:602–610.
   PubMed Web of Science ®Google Scholar
• Caponi S, Vasile E, Funel N, et al. Adjuvant chemotherapy seems beneficial for invasive intraductal papillary mucinous neoplasms. Eur J Surg Oncol. 2013;39:396–403.
   PubMed Web of Science ®Google Scholar
• Alexander BM, Fernandez-Del Castillo C, et al. Intraductal papillary mucinous adenocarcinoma of the pancreas: clinical outcomes, prognostic factors, and the role of adjuvant therapy. Gastrointest Cancer Res. 2011;4:116–121.
   PubMedGoogle Scholar
• Swartz MJ, Hsu CC, Pawlik TM, et al. Adjuvant chemoradiotherapy after pancreatic resection for invasive carcinoma associated with intraductal papillary mucinous neoplasm of the pancreas. Int J Radiat Oncol Biol Phys. 2010;76:839–844.
   PubMed Web of Science ®Google Scholar
• Worni M, Akushevich I, Gloor B, et al. Adjuvant radiotherapy in the treatment of invasive intraductal papillary mucinous neoplasm of the pancreas: an analysis of the surveillance, epidemiology, and end results registry. Ann Surg Oncol. 2012;19:1316–1323.
   PubMed Web of Science ®Google Scholar
• Turrini O, Waters JA, Schnelldorfer T, et al. Invasive intraductal papillary mucinous neoplasm: predictors of survival and role of adjuvant therapy. HPB (Oxford). 2010;12:447–455.
   PubMed Web of Science ®Google Scholar
• Macgregor-Das AM, Iacobuzio-Donahue CA. Molecular pathways in pancreatic carcinogenesis. J Surg Oncol. 2013;107:8–14.
   PubMed Web of Science ®Google Scholar
• Hayashi T, Ishiwatari H, Ihara H, et al. Suppressive effect of sulindac on branch duct-intraductal papillary mucinous neoplasms. J Gastroenterol. 2009;44:964–975.
   PubMed Web of Science ®Google Scholar
• Crippa S, Pezzilli R, Bissolati M, et al. Active surveillance beyond 5 years is required for presumed branch-duct intraductal papillary mucinous neoplasms undergoing non-operative management. Am J Gastroenterol. 2017. [Epub ahead of print]. DOI: 10.1038/ajg.2017.43
   PubMed Web of Science ®Google Scholar
• Khaled YS, Mohsin M, Fatania K, et al. Outcome of long interval radiological surveillance of side branch pancreatic duct-involved intraductal papillary mucinous neoplasm in selected patients. HPB (Oxford). 2016;18:879–885.
   PubMed Web of Science ®Google Scholar
• Yan L, Siddiqui AA, Laique SN, et al. A large multicenter study of recurrence after surgical resection of branch-duct intraductal papillary mucinous neoplasm of the pancreas. Minerva Gastroenterol Dietol. 2017;63:50–54.
   PubMed Web of Science ®Google Scholar
• Pezzilli R, Calculli L. Branch-type intraductal papillary mucinous neoplasm of the pancreas: clinically and patient-reported outcomes. Pancreas. 2015;44:221–226.
   PubMed Web of Science ®Google Scholar
• Valsangkar NP, Morales-Oyarvide V, Thayer SP, et al. 851 Resected cystic tumors of the pancreas: a 33-year experience at the Massachusetts General Hospital. Surgery. 2012;152:S4–S12.
   PubMed Web of Science ®Google Scholar
• Cameron JL, He J. Two thousand consecutive pancreaticoduodenectomies. J Am Coll Surg. 2015;220:530–536.
   PubMed Web of Science ®Google Scholar
• He J, Ahuja N, Makary MA, et al. 2564 Resected periampullary adenocarcinomas at a single institution: trends over three decades. HPB (Oxford). 2014;16:83–90.
   PubMed Web of Science ®Google Scholar
• Almond M, Roberts KJ, Hodson J, et al. Changing indications for a total pancreatectomy: perspectives over a quarter of a century. HPB (Oxford). 2015;17:416–421.
   PubMed Web of Science ®Google Scholar
• Schoeni RF, Ofstedal MB. Key themes in research on the demography of aging. Demography. 2010;47 Suppl:S5–S15.
   PubMed Web of Science ®Google Scholar
• Huang ES, Gazelle GS, Hur C. Consensus guidelines in the management of branch duct intraductal papillary mucinous neoplasm: a cost-effectiveness analysis. Dig Dis Sci. 2010;55:852–860.
   PubMed Web of Science ®Google Scholar
• Weinberg BM, Spiegel BM, Tomlinson JS, et al. Asymptomatic pancreatic cystic neoplasms: maximizing survival and quality of life using Markov-based clinical nomograms. Gastroenterology. 2010;138:531–540.
   PubMed Web of Science ®Google Scholar
• Das A, Ngamruengphong S, Nagendra S, et al. Asymptomatic pancreatic cystic neoplasm: a cost-effectiveness analysis of different strategies of management. Gastrointest Endosc. 2009;70:690–699.e6.
   PubMed Web of Science ®Google Scholar